Quintiles Transitional Holdings Inc. (NYSE:Q)‘s stock had its “sector weight” rating reiterated by KeyCorp in a research note issued on Friday. They currently have a $100.00 price target on the medical research company’s stock. KeyCorp’s price target would indicate a potential downside of 3.89% from the company’s current price.
Other equities research analysts have also recently issued research reports about the company. Barclays PLC reaffirmed an “overweight” rating and set a $98.00 price target (up previously from $90.00) on shares of Quintiles Transitional Holdings in a report on Monday, July 17th. Zacks Investment Research raised Quintiles Transitional Holdings from a “hold” rating to a “buy” rating and set a $101.00 target price on the stock in a report on Thursday, July 27th. William Blair raised Quintiles Transitional Holdings from a “market perform” rating to an “outperform” rating and boosted their target price for the stock from $70.10 to $93.42 in a report on Friday, August 4th. Jefferies Group LLC reissued a “hold” rating and set a $94.00 target price on shares of Quintiles Transitional Holdings in a report on Friday, August 4th. Finally, Stifel Nicolaus reissued a “hold” rating and set a $92.00 target price (up previously from $87.00) on shares of Quintiles Transitional Holdings in a report on Friday, August 4th. Eleven equities research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company’s stock. Quintiles Transitional Holdings presently has an average rating of “Buy” and a consensus price target of $103.15.
Quintiles Transitional Holdings (NYSE:Q) traded up $0.54 during trading hours on Friday, reaching $104.05. The company had a trading volume of 1,138,100 shares, compared to its average volume of 1,591,800. The firm has a market capitalization of $21,987.17, a P/E ratio of 23.76, a price-to-earnings-growth ratio of 1.73 and a beta of 0.65. Quintiles Transitional Holdings has a fifty-two week low of $71.90 and a fifty-two week high of $110.67. The company has a quick ratio of 1.22, a current ratio of 1.22 and a debt-to-equity ratio of 1.29.
Quintiles Transitional Holdings (NYSE:Q) last issued its earnings results on Thursday, October 26th. The medical research company reported $1.19 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.14 by $0.05. Quintiles Transitional Holdings had a net margin of 0.58% and a return on equity of 12.60%. The firm had revenue of $2.02 billion for the quarter, compared to analysts’ expectations of $2.01 billion. During the same quarter last year, the company posted $1.00 earnings per share. Quintiles Transitional Holdings’s revenue was up 77.6% on a year-over-year basis. analysts expect that Quintiles Transitional Holdings will post 4.62 earnings per share for the current fiscal year.
In related news, major shareholder Cpp Investment Board Private H sold 5,218,245 shares of the company’s stock in a transaction dated Monday, August 28th. The shares were sold at an average price of $97.33, for a total value of $507,891,785.85. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Ari Bousbib sold 46,080 shares of the company’s stock in a transaction dated Friday, September 1st. The shares were sold at an average price of $95.65, for a total transaction of $4,407,552.00. Following the completion of the sale, the insider now directly owns 1,036,839 shares in the company, valued at approximately $99,173,650.35. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 14,175,702 shares of company stock worth $1,361,299,848. Insiders own 6.40% of the company’s stock.
Institutional investors have recently modified their holdings of the business. Sun Life Financial INC acquired a new position in shares of Quintiles Transitional Holdings during the third quarter worth approximately $106,000. Fiduciary Trust Co. acquired a new position in shares of Quintiles Transitional Holdings during the second quarter worth approximately $105,000. Korea Investment CORP lifted its position in shares of Quintiles Transitional Holdings by 142.5% during the second quarter. Korea Investment CORP now owns 1,370 shares of the medical research company’s stock worth $123,000 after purchasing an additional 805 shares in the last quarter. GWM Advisors LLC acquired a new position in shares of Quintiles Transitional Holdings during the second quarter worth approximately $122,000. Finally, Citigroup Inc. lifted its position in shares of Quintiles Transitional Holdings by 15.5% during the second quarter. Citigroup Inc. now owns 1,858 shares of the medical research company’s stock worth $167,000 after purchasing an additional 250 shares in the last quarter. 94.04% of the stock is currently owned by hedge funds and other institutional investors.
About Quintiles Transitional Holdings
Quintiles IMS Holdings, Inc, formerly Quintiles Transnational Holdings Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.
Receive News & Ratings for Quintiles Transitional Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quintiles Transitional Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.